Top 5 Dow Dividend Companies To Invest In Right Now

This was inevitable. With Apple's (NASDAQ: AAPL  ) continued share weakness as Google (NASDAQ: GOOG  ) keeps on marching higher, the search giant was bound to overtake the Mac maker in one important valuation metric: enterprise value.

Enterprise value is calculated as market capitalization plus debt minus cash. Just looking at market cap, Apple still has Google beat by a long shot with its $378 billion well ahead of Big G's $287 billion. It's factoring in the cash positions that turn the tables in favor of the search giant. The Wall Street Journal estimates Apple's enterprise value at $233.2 billion, with Google just now squeezing ahead at $240.6 billion.

Apple has historically had no debt, and initially its $17 billion bond offering had no impact on enterprise value since the company raised an equal amount of cash. However, the market value of Apple's debt has declined since then along with the broader bond market in part due to macro factors like the Fed preparing to reduce its bond purchasing. Apple's paper has declined in aggregate value by roughly $760 million since then, hurting its enterprise value.

Top Safest Stocks To Invest In 2015: Sealand Natural Resources Inc (SLNR)

Sealand Natural Resources Inc. (SLNR), incorporated on May 13, 2011, is a research and new product development company that manufactures, markets and sells new age functional beverages (SealandBirk), organic nutriceuticals, health supplements, medicinal raw materials and health food worldwide. SLNR specializes in research of natural new product development and mass market consumer product distribution. Its Products include Sealand BIRK, Sealand Living and Sealand research and development (R&D). Sealand Living Anew products offer supply of healing nutrients to athletic training.

Anew omega premium is a food supplement consists of shark cartilage powder, fish bone powder, and omega three polyunsaturated fatty acids. Anew omega premium is designed to reduce the decomposition, to stimulate resynthesis of the joint cartilage and to reduce pain. Omega Premium consists of shark cartilage powder, codfish backbone powder, and fish oil powder. Anew nutripeptin is a food supply. Sealand BIRK consists of five flavors original, elderflower, raspberry, blueberry, ginger and lime.

Advisors' Opinion:

• [By CRWE]

  Today, SLNR has shed (-0.14%) down -0.01 at $7.27 with 125 shares in play thus far (ref. google finance Delayed: 11:13AM EDT June 28, 2013), but don�� let this get you down.

  Sealand Natural Resources Inc. previously reported recent company milestones as of May 31, 2013.

  Lars Poulsen, Chief Executive Officer of Sealand Natural Resources Inc., commented, ��ealand BIRK beverage has made significant progress on a number of important fronts. Sealand BIRK is a ‘first mover,’ in the market place offering a unique organic harvested beverage, packed with micro nutrients, no added sugar, less than 60 calories with health hydration attributes for consumers. In the market today, only extremes are available for consumers, ranging from water to high sugar, high calorie, nutritionally-deficient beverages. We organically harvest and deliver Sealand BIRK beverages for consumers that encourage improved health, while being clear that our products have key differentiating factors that set us apart from the competition.

• [By CRWE]

  Today, SLNR remains (0.00%) +0.000 at $7.23 with 100 shares in play thus far (ref. google finance Delayed: 10:29AM EDT June 24, 2013).

  Sealand Natural Resources Inc. previously reported recent company milestones as of May 31, 2013.

  Lars Poulsen, Chief Executive Officer of Sealand Natural Resources Inc., commented, ��ealand BIRK beverage has made significant progress on a number of important fronts. Sealand BIRK is a ‘first mover,’ in the market place offering a unique organic harvested beverage, packed with micro nutrients, no added sugar, less than 60 calories with health hydration attributes for consumers. In the market today, only extremes are available for consumers, ranging from water to high sugar, high calorie, nutritionally-deficient beverages. We organically harvest and deliver Sealand BIRK beverages for consumers that encourage improved health, while being clear that our products have key differentiating factors that set us apart from the competition.

• [By CRWE]

  Last Friday, SLNR previously surged (+0.27%) up +0.02 at $7.43 with 425 shares in play at the close (ref. google finance July 26, 2013 ��Close).

  Sealand Natural Resources Inc. previously reported it has reached a distribution agreement with Nature’s Best.

  Nature’s Best, in business since 1969, is the largest privately owned wholesaler-distributor of health and natural food products in the Natural Products Industry. Nature’s Best provides a full-line of Certified Organic, Natural and Specialty products to retail stores throughout the Central, Southern and Western U.S., Alaska, Hawaii and Asia. Nature’s Best specializes in Retail Marketing Support, Web Services, Business Analysis Tools and Sales/Category Management Consulting.

Top 5 Dow Dividend Companies To Invest In Right Now: Chilean Metals Inc (CMX)

Chilean Metals Inc, formerly International PBX Ventures Ltd., is an exploration-stage company. The Company is engaged in exploring for gold, silver, copper and molybdenum on its various properties located in Chile through its wholly owned subsidiaries in Chile, Minera IPBX Limitada, Minera Tierra de Oro Limitada, Minera Palo Negro Limitada and Minera Sierra Pintada Limitada. The Company owns 100% interest in Copaquire Project. The Copaquire property is approximately 20 kilometer west of the Collahuasi mine and 8 kilometer west of the Quebrada Blanca copper-molybdenum mine properties. The Tierra de Oro property lies about 30 kilometers south of the Candelaria copper-gold-silver mines. Through its 100% owned Chilean Metals Exploration Ltd. the Company owns six Gold-Copper properties strategically located in the prolific IOCG belt of Chile. Advisors' Opinion:

• [By Johanna Bennett]

  It�� a good day for auto dealer stocks. CarMax (CMX) got engines revving on Wall Street when it posted blowout quarterly results. And Goldman Sachs upgraded AutoNation (AN) from Neutral to Buy and set a six-month price target of $65, citing the company�� growth prospects, margins and balance sheet.

  The AutoNation upgrade was actually part of a broader industry call by analysts Patrick Archambault and David Tamberrino. In a 32-page note published today,�the pair raised estimates for auto dealers, citing increased SAAR projections for 2014 through 2016 and growth opportunity�� from M&A. Archambault and Tamberrino write:

  The combination of these factors drives up our 2015/2016 EPS estimates to 2.4% and 6.1% above the Street which we believe is understating the sector�� growth potential. M&A is the key growth opportunity. About 2 points of our 3% profit revision comes from M&A. With $2.4bn of dry powder, a still very fragmented dealer group, and reasonable valuations on the private side we think the risk is to the upside for acquisitions. M&A has added 2.4% to dealer revenue growth annually over the past 5 years which we assume continues.

  AutoNation rose 2.7% to $58.04, while CarMax surged 15.6% to $52.32

  �

Top 5 Dow Dividend Companies To Invest In Right Now: NanoViricides Inc (NNVC)

NanoViricides, Inc., incorporated on April 1, 2005, is a development-stage company. The Company is a nano-biopharmaceutical (nanomedicine) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections. The Company has several drugs in various stages of early development. The Company�� drugs are based on several patents, patent applications, provisional patent applications, and other property held by TheraCour Pharma, Inc. (TheraCou), to which the Company has exclusive licenses in perpetuity for the treatment of human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Influenza including Asian Bird Flu Virus (INF), Herpes Simplex Virus (HSV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Rabies. As of June 30, 2012, the Company had six drug development programs: Oral FluCideTM, against all Influenzas; a Piggy-back version of Flucide for hospitalized patients; nanoviricide eye drops against adenoviral EKC and herpes keratitis; HIVCide - I against HIV/AIDS; HerpeCide - I skin cream formulation for herpes cold sores and genital warts, and DengueCide, a broad spectrum nanoviricide designed to attack all types of dengue viruses and expected to be effective in the Severe Dengue Disease syndromes including Dengue Hemorrhagic Fever (DHS) and Dengue Shock Syndrome (DSS). As of June 30, 2012, it had engaged in organizational activities, sourcing compounds and materials, developing novel compounds and nanomaterials, and experimentation with studies on cell cultures and animals. In September 2011, NanoViricides Inc's Inno-Haven LLC acquired a light industrial building.

The Company's product development programs are divided into three sectors: commercially important diseases, neglected tropical diseases (NTD��) and biosecurity/biodefense, and advanced technologies. The Company has collaborations with KARD Scientific, Inc., MA. and Southern Research Institute, AL for influenza viruse! s; National (Central) Institute of Hygiene and Epidemiology (NIHE) (Vietnam), for H5N1 avian flu; The Long Island Jewish Medical System, Feinstein Institute of Medical Research (LIJMS), NY and TheVac, LLC. for viral diseases of the eye (adenoviruses, herpesviruses - epidemic kerato-conjunctivitis (EKC), Herpes Keratitis); TheVac, LLC and Northeastern Ohio Medical University (NEOMED) for herpes virus infections; University of California at Berkeley for dengue hemorrhagic fever viruses; Center for Disease Control and Prevention (CDC) and National (Central) Institute of Hygiene and Epidemiology for rabies virus. The Company has developed lead drug candidates against a number of viral diseases.

The Company had consolidated all of its influenza drug programs into a single pan-influenza FluCide program. It is developing a single drug for all influenzas, whether pandemic, epidemic, seasonal, novel, emerging, human, swine, or avian. It is developing a nanoviricide against adenoviral EKC. The nanoviricide eye drug candidate is formulated as simple eye drops. It is developing an anti-HSV nanoviricide skin cream formulation for direct application to the lesions. It has designed the anti-HIV nanoviricides using rational drug design principles. The ligands it has designed in the case of HIV-1 are thought to be broadly neutralizing. In-silico modeling indicates that its ligands dock to the conserved CD4 binding site of gp120 of HIV-1. The Company is working on developing anti-Dengue therapeutics. Dengue is an important NTD. Its RabiCide program has resulted in candidates that have enabled survival of 20% to 30% of infected animals after disease has set in, using a particular animal model.

The Company competes with Roche, Glaxo SmithKline, BioCryst Pharmaceuticals, Inc., Gilead, Bristol-Myers Squibb Company (BMS), Roche, Boehringer Ingelheim, Merck & Co., Inc. (Merck), Valeant, Schering, Pharmassett, Vertex, Intermune, Achillion and Novartis.

Advisors' Opinion:

• [By Roberto Pedone]

  
  

  One under-$10 nano-biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Nanoviricides (NNVC), which engages in the discovery, development and commercialization of anti-viral therapeutics primarily in the U.S. This stock has been ripping to the upside so far in 2013, with share up big by 198%.

  If you take a look at the chart for Nanoviricides, you'll notice that this stock has recently formed a double bottom chart pattern at $4.55 to $4.52 a share. Following that bottom, shares of NNVC have now started to uptrend and move within range of triggering a big breakout trade. That trade will hit if NNVC manages to take out the upper-end of its recent sideways trading chart pattern, which has seen NNVC trend between $4.55 and $5.74 a share.

  Traders should now look for long-biased trades in NNVC if it manages to break out above some near-term overhead resistance levels at Friday's high of $4.94 a share to its 50-day moving average of $5.28 a share, and then once it takes out some more key overhead resistance levels at $5.72 to $5.74 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 234,994 shares. If that breakout triggers soon, then NNVC will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to its 52-week high at $7.59 a share.

  Traders can look to buy NNVC off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.55 to $4.52 a share. One can also buy NNVC off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Dow Dividend Companies To Invest In Right Now: Primco Management Inc (PMCM)

Primco Management Inc., incorporated on October 14, 2010, is a development-stage company. The Company focuses on offering estate management services for its clients and retention on a range of properties including class A office space, industrial, manufacturing, and warehousing facilities as well as data centers and retail outlets for real estate users. In addition, it also focuses on offering consulting services, including site selection, feasibility studies, exit strategies, market forecasts, strategic planning, and research services. In February 2013, the Company announced that ESMG, Inc. took controlling interest in the Company through the acquisition of more than 80% interest of the Company. In February 2013, it purchased the music catalog of D&B Music. In May 2013, the Company acquired Top Sail Productions.

As of December 31, 2010, the Company did not have any operations. During the year ended December 31, 2010, it did not generate any revenues.

Advisors' Opinion:

• [By Peter Graham]

  The marijuana field keeps sprouting small cap marijuana stocks like Primco Management Inc (OTCBB: PMCM), Medifirst Solutions Inc (OTCMKTS: MFST) and Modern Mobility Aids, Inc (OTCMKTS: MDRM) which are all trying to seek a high by playing up their connections (no matter how tenuous�� to what many consider to be the next high flying sector. But are these small cap marijuana stocks just blowing smoke at investors? Here is a quick reality check: